0,982  0,001  Antihypercholesterolemic
0,973  0,002  TNF expression inhibitor
0,965  0,002  Chemopreventive
0,956  0,001  Cholesterol antagonist
0,924  0,003  Chemoprotective
0,918  0,001  UGT1A3 substrate
0,909  0,005  Transcription factor NF kappa B inhibitor
0,886  0,002  Proliferative diseases treatment
0,869  0,002  UGT2B1 substrate
0,867  0,002  Anesthetic
0,864  0,004  Caspase 9 stimulant
0,859  0,003  UGT1A6 substrate
0,857  0,006  Teratogen
0,849  0,002  Sulfotransferase substrate
0,837  0,004  Sensitization
0,832  0,005  Respiratory analeptic
0,832  0,005  Carcinogenic
0,829  0,008  CYP3A4 substrate
0,821  0,000  Cholesterol synthesis inhibitor
0,824  0,004  NOS2 expression inhibitor
0,818  0,008  Embryotoxic
0,793  0,003  UGT1A1 substrate
0,785  0,002  Antihyperlipoproteinemic
0,797  0,017  Apoptosis agonist
0,774  0,003  UGT1A4 substrate
0,754  0,003  Hair growth stimulant
0,744  0,001  Choleretic
0,752  0,009  CYP2C9 substrate
0,745  0,003  Anesthetic general
0,757  0,021  Antiinflammatory
0,735  0,006  CYP2C19 substrate
0,730  0,005  Hepatic disorders treatment
0,725  0,002  Antipruritic, allergic
0,711  0,001  UGT2B4 substrate
0,714  0,005  NOS3 expression inhibitor
0,713  0,007  Analeptic
0,723  0,017  Antineoplastic (breast cancer)
0,701  0,007  Bone diseases treatment
0,678  0,003  Phospholipase C inhibitor
0,680  0,006  Lipoprotein disorders treatment
0,678  0,021  Antineoplastic (lung cancer)
0,660  0,008  Antiosteoporotic
0,614  0,011  Cytotoxic
0,602  0,007  UDP-glucuronosyltransferase substrate
0,595  0,002  UGT2B7 substrate
0,594  0,010  Apoptosis antagonist
0,577  0,002  Pregnane X receptor agonist
0,560  0,002  Sodium/bile acid cotransporter inhibitor
0,562  0,008  Hypolipemic
0,566  0,013  AR expression inhibitor
0,562  0,014  Antioxidant
0,571  0,028  Antileukemic
0,559  0,016  CTGF expression inhibitor
0,553  0,024  Prostate cancer treatment
0,532  0,004  Interferon gamma antagonist
0,534  0,008  Amyotrophic lateral sclerosis treatment
0,527  0,004  Protein kinase stimulant
0,521  0,006  Prostatic (benign) hyperplasia treatment
0,537  0,022  Antineoplastic (ovarian cancer)
0,534  0,020  Antineoplastic (melanoma)
0,513  0,003  LDLR expression enhancer
0,498  0,003  Anticataract
0,494  0,005  Prostate disorders treatment
0,503  0,016  Nitric oxide antagonist
0,499  0,015  Antipyretic
0,516  0,036  Antibacterial
0,487  0,008  Muscle relaxant
0,486  0,008  Hepatoprotectant
0,510  0,034  Antineoplastic (colorectal cancer)
0,478  0,004  Antipruritic, non-allergic
0,482  0,011  Antineoplastic (renal cancer)
0,502  0,032  Immunosuppressant
0,492  0,023  Antineoplastic (cervical cancer)
0,488  0,020  Antineoplastic (glioma)
0,479  0,012  Sedative
0,488  0,024  Antifungal
0,494  0,034  Antineoplastic (colon cancer)
0,490  0,030  Immunostimulant
0,507  0,048  Antidiabetic
0,507  0,048  Cyclophilin D inhibitor
0,462  0,004  UGT2B9 substrate
0,455  0,001  Anticholelithogenic
0,462  0,009  Melanin inhibitor
0,477  0,024  Antipsoriatic
0,487  0,035  Atherosclerosis treatment
0,464  0,013  Antineoplastic (liver cancer)
0,455  0,007  Platelet adhesion inhibitor
0,449  0,007  Antiacne
0,445  0,006  Lipocortins synthesis antagonist
0,460  0,020  Free radical scavenger
0,457  0,019  Antineoplastic (glioblastoma multiforme)
0,447  0,012  P-glycoprotein inhibitor
0,439  0,005  Antifungal enhancer
0,443  0,010  Abortion inducer
0,449  0,028  Antineoplastic (pancreatic cancer)
0,448  0,031  Spasmolytic
0,440  0,025  Antineoplastic (multiple myeloma)
0,437  0,030  Antineoplastic (brain cancer)
0,418  0,012  Contraceptive
0,434  0,029  Metabolic disease treatment
0,406  0,009  Amylase inhibitor
0,424  0,034  Radioprotector
0,421  0,031  UGT1A9 substrate
0,408  0,020  Antihypertriglyceridemic
0,417  0,039  Caspase 3 stimulant
0,398  0,021  Antineoplastic (endocrine cancer)
0,378  0,002  5-Alpha-reductase inhibitor
0,409  0,037  ICAM1 expression inhibitor
0,379  0,007  DNA polymerase I inhibitor
0,390  0,023  Angiogenesis stimulant
0,370  0,005  Antiinfertility, female
0,434  0,076  Alzheimer's disease treatment
0,360  0,005  Autism spectrum disorders treatment
0,358  0,004  Farnesoid X receptor antagonist
0,383  0,030  Antineoplastic (lymphoma)
0,385  0,035  Antineoplastic (non-small cell lung cancer)
0,363  0,015  Skin whitener
0,379  0,035  Antiprotozoal (Leishmania)
0,345  0,003  Bile acid receptor antagonist
0,386  0,045  Antihypertensive
0,373  0,034  Antiamyloidogenic
0,343  0,010  Antidiarrheal
0,335  0,002  5-Alpha-reductase 2 inhibitor
0,367  0,034  Hypoglycemic
0,363  0,037  DNA damaging
0,330  0,007  Expectorant
0,329  0,013  Liver fibrosis treatment
0,318  0,004  UGT2B10 substrate
0,366  0,052  CYP2D6 substrate
0,349  0,037  Cardiodepressant
0,319  0,015  UGT2B15 substrate
0,325  0,024  Antiviral (Influenza)
0,320  0,020  VCAM1 expression inhibitor
0,306  0,008  Liver cirrhosis treatment
0,307  0,016  Antiviral (Influenza A)
0,343  0,054  Antiepileptic
0,290  0,004  CDC25A inhibitor
0,352  0,073  Vasodilator, peripheral
0,327  0,048  Antihypoxic
0,275  0,001  Cholesterol absorption inhibitor
0,320  0,049  Renal disease treatment
0,289  0,019  NOS3 expression enhancer
0,277  0,008  Androgen antagonist
0,283  0,019  Growth factor agonist
0,312  0,049  Tumour necrosis factor alpha release inhibitor
0,303  0,040  Antineoplastic (sarcoma)
0,265  0,004  Arachidonic acid antagonist
0,279  0,020  Monophenol monooxygenase inhibitor
0,330  0,072  Antithrombotic
0,300  0,043  Antiulcerative
0,259  0,006  Microtubule formation inhibitor
0,258  0,009  Retinoprotector
0,327  0,083  Inflammatory Bowel disease treatment
0,303  0,061  Antidiabetic (type 2)
0,270  0,028  Neurotrophic factor enhancer
0,292  0,052  Interleukin agonist
0,244  0,009  Contraceptive female
0,240  0,014  Neurotrophic factor
0,297  0,072  Cardioprotectant
0,255  0,031  Antiviral (Herpes)
0,223  0,003  UGT2B11 substrate
0,267  0,053  Amyloid beta aggregation inhibitor
0,261  0,049  Antineoplastic enhancer
0,220  0,014  Alcohol dehydrogenase substrate
0,269  0,064  Vascular (periferal) disease treatment
0,210  0,010  Vanilloid 1 agonist
0,247  0,050  Wound healing agent
0,282  0,088  Interleukin 2 agonist
0,218  0,024  Protein-tyrosine phosphatase 1B inhibitor
0,270  0,083  Hypoxia-inducible factor 1 alpha inhibitor
0,220  0,034  Lipid peroxidase inhibitor
0,221  0,039  Protein-tyrosine phosphatase inhibitor
0,251  0,072  Cardiovascular analeptic
0,239  0,062  Antiviral (HIV)
0,179  0,003  Farnesoid X receptor agonist
0,249  0,075  Antidiabetic symptomatic
0,300  0,126  CYP2C19 inhibitor
0,223  0,052  Insulin sensitizer
0,179  0,011  HIV-1 integrase (Strand Transfer) inhibitor
0,171  0,003  5-Alpha-reductase 1 inhibitor
0,201  0,040  Interleukin 6 antagonist
0,207  0,047  VEGF expression inhibitor
0,279  0,120  Stroke treatment
0,239  0,081  Myocardial infarction treatment
0,181  0,023  Growth stimulant
0,160  0,004  Na+ K+ transporting ATPase inhibitor
0,175  0,021  Mucolytic
0,169  0,015  Actinic keratosis treatment
0,162  0,015  Toll-Like receptor 4 antagonist
0,183  0,037  Anesthetic local
0,192  0,046  Antineoplastic (bone cancer)
0,159  0,015  ABCA1 expression enhancer
0,218  0,074  Antimitotic
0,157  0,014  Anabolic
0,239  0,098  Antituberculosic
0,198  0,059  Diabetic nephropathy treatment
0,145  0,008  Hyperparathyroidism treatment
0,201  0,067  Antihelmintic
0,222  0,088  Vasodilator
0,138  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,158  0,025  Antineoplastic alkaloid
0,145  0,012  Estrogen agonist
0,153  0,022  Estrogen antagonist
0,248  0,117  Immunomodulator
0,131  0,004  Liver X receptor alpha agonist
0,168  0,042  Skin irritative effect
0,270  0,147  Antiprotozoal
0,128  0,005  Botulinum neurotoxin type A inhibitor
0,139  0,016  Keratolytic
0,128  0,009  CDC25B inhibitor
0,237  0,118  Antimycobacterial
0,190  0,072  Mutagenic
0,159  0,041  Proteasome inhibitor
0,133  0,016  HIV-1 integrase (3'-Processing) inhibitor
0,208  0,092  Cytostatic
0,167  0,053  Skeletal muscle relaxant
0,130  0,016  Estrogen receptor alpha antagonist
0,124  0,011  Glycine receptor agonist
0,121  0,008  Hypercalcemia treatment
0,163  0,050  Bone formation stimulant
0,175  0,064  Antimutagenic
0,139  0,031  Dementia treatment
0,113  0,005  RNA-directed RNA polymerase stimulant
0,134  0,030  Vascular dementia treatment
0,172  0,071  Toxic, respiratory center
0,134  0,035  Antineoplastic antibiotic
0,108  0,012  Androgen agonist
0,187  0,097  Antiparasitic
0,095  0,004  Heparanase inhibitor
0,090  0,001  Vitamin D receptor agonist
0,146  0,059  Antieczematic
0,141  0,055  Antihemorrhagic
0,150  0,065  Antineoplastic (squamous cell carcinoma)
0,121  0,037  Prolactin inhibitor
0,092  0,008  Lipocortins synthesis agonist
0,191  0,108  Platelet antagonist
0,189  0,107  Antineoplastic (lymphocytic leukemia)
0,235  0,154  Antiprotozoal (Plasmodium)
0,089  0,009  Glucose-6-phosphate translocase inhibitor
0,186  0,107  Age-related macular degeneration treatment
0,239  0,160  Calcium channel activator
0,153  0,075  Diuretic
0,095  0,018  Postmenopausal disorders treatment
0,101  0,024  SULT1A2 substrate
0,087  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,104  0,029  Vanilloid agonist
0,160  0,085  Male reproductive disfunction treatment
0,138  0,064  Tubulin antagonist
0,076  0,003  Ileal bile acid transport inhibitor
0,113  0,041  Estrogen receptor beta antagonist
0,203  0,130  Transcription factor STAT3 inhibitor
0,147  0,079  Acute respiratory distress syndrome (ARDS) treatment
0,146  0,079  Insulin secretagoues
0,071  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,189  0,123  Antihypotensive
0,131  0,066  Cyclooxygenase 3 inhibitor
0,067  0,004  Vitamin D receptor antagonist
0,075  0,013  Potassium channel Kv1.3 blocker
0,081  0,021  Nitric oxide donor
0,067  0,008  Parathyroid hormone antagonist
0,101  0,043  Ornithine decarboxylase inhibitor
0,099  0,041  ATPase (Vacuolar H+) inhibitor
0,123  0,065  Alkylator
0,133  0,076  Psychosexual dysfunction treatment
0,069  0,013  Liver X receptor agonist
0,075  0,020  Heme oxygenase stimulant
0,081  0,027  Aromatase inhibitor
0,071  0,016  Acetyl-CoA transferase 2 inhibitor
0,096  0,043  Contraceptive male
0,056  0,003  Hedgehog signaling activator
0,101  0,048  SULT1E1 substrate
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,137  0,088  Adenylate cyclase stimulant
0,112  0,064  SULT1A1 substrate
0,052  0,006  HMG CoA reductase inhibitor
0,089  0,044  Glycine receptor antagonist
0,106  0,062  HDL-cholesterol increasing
0,081  0,040  Antitreponemal
0,198  0,157  CYP1A2 substrate
0,104  0,065  AMP-activated protein kinase stimulant
0,065  0,027  Acetyl-CoA transferase inhibitor
0,051  0,014  Glucocorticoid antagonist
0,132  0,097  Eye irritation, high
0,113  0,079  Antiviral (Hepatitis B)
0,092  0,058  Paget's disease treatment
0,055  0,021  Microtubule stabilization
0,128  0,096  Antidote
0,087  0,055  Transcription factor NF kappa B stimulant
0,038  0,007  CYP24 inhibitor
0,061  0,032  Postcoital contraceptive
0,130  0,101  Phospholipase A2 inhibitor
0,066  0,037  Beta tubulin antagonist
0,032  0,005  Apical sodium codependent bile acid transporter inhibitor
0,205  0,179  Antineoplastic (osteosarcoma)
0,089  0,067  Breast cancer-resistant protein inhibitor
0,095  0,074  Hedgehog signaling inhibitor
0,106  0,086  Antiseptic
0,039  0,021  Estrogen receptor alpha agonist
0,116  0,098  Antineoplastic (carcinoma)
0,031  0,013  1,3-Beta-glucan synthase inhibitor
0,053  0,038  Alpha tubulin antagonist
0,088  0,075  Lanosterol 14 alpha demethylase inhibitor
0,102  0,088  Aldehyde dehydrogenase substrate
0,132  0,119  Antipruritic
0,014  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,085  0,076  Butyrylcholinesterase inhibitor
0,022  0,014  Corticosteroid-like
0,033  0,027  Tubulin agonist
0,128  0,123  Diabetic retinopathy treatment
0,093  0,088  Chelator
0,064  0,059  HIV-1 integrase inhibitor
0,064  0,062  Antibiotic
0,019  0,018  Estrone sulfatase inhibitor
0,003  0,003  Vitamin D-like

